+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2019 Binge Eating Disorder Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767298
  • Report
  • 98 pages
  • VPA Research
1 of 4

FEATURED COMPANIES

  • Allergan Plc
  • Johnson & Johnson
  • Lotus Labs Pvt Ltd
  • QPS Holdings LLC
  • Radiant Research Inc
  • Shire Plc
  • MORE
The global clinical trial report- “2019 Binge Eating Disorder Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Binge Eating Disorder. It presents in-depth analysis of Binge Eating Disorder clinical trials across markets and companies. The research work is for providing complete understanding into trends in Binge Eating Disorder.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Binge Eating Disorder clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Binge Eating Disorder

The research work is prepared through extensive and continuous research on Binge Eating Disorder trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Binge Eating Disorder patients are identified
  • The report includes panorama of Binge Eating Disorder clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Binge Eating Disorder clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Allergan Plc
  • Johnson & Johnson
  • Lotus Labs Pvt Ltd
  • QPS Holdings LLC
  • Radiant Research Inc
  • Shire Plc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Binge Eating Disorder Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Binge Eating Disorder Clinical Trials by Region
2.2.2 Average Enrollment of Binge Eating Disorder Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Binge Eating Disorder Treatment, 2019

3. Region wise Binge Eating Disorder Clinical Trials
3.1 Asia Pacific Binge Eating Disorder Clinical Trials by Country
3.2 Europe Binge Eating Disorder Clinical Trials by Country
3.3 North America Binge Eating Disorder Clinical Trials by Country
3.4 Middle East and Africa Binge Eating Disorder Clinical Trials by Country
3.5 South and Central America Binge Eating Disorder Clinical Trials by Country

4. Binge Eating Disorder Clinical Trial Trends
4.1 Start Year wise Binge Eating Disorder Clinical Trials
4.2 Phase wise Binge Eating Disorder Clinical Trials
4.3 Trial Status wise Binge Eating Disorder Clinical Trials
4.4 Trial Type wise Binge Eating Disorder Clinical Trials

5. Binge Eating Disorder Average Enrollment Trends
5.1 Average Enrollment in Binge Eating Disorder Trials by Year
5.2 Average Enrollment in Binge Eating Disorder Trials by Phase
5.3 Average Enrollment in Binge Eating Disorder Trials by Status
5.4 Average Enrollment in Binge Eating Disorder Trials by Type of Trial

6. Companies Participating in Binge Eating Disorder Clinical Trials
6.1 Binge Eating Disorder Trials by Sponsor Type
6.2 Binge Eating Disorder Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Binge Eating Disorder Trials- Phase 1
7.2 Binge Eating Disorder Trials- Phase 2
7.3 Binge Eating Disorder Trials- Phase 3
7.4 Binge Eating Disorder Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Binge Eating Disorder Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Binge Eating Disorder Clinical Trials and Enrolment
Figure 5: Europe - Country wise Binge Eating Disorder Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Binge Eating Disorder Clinical Trials and Enrolment
Figure 7: North America - Country wise Binge Eating Disorder Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Binge Eating Disorder Clinical Trials and Enrolment
Figure 9: Binge Eating Disorder Clinical Trials by Phase
Figure 10: Binge Eating Disorder Clinical Trials by Trial Status
Figure 11: Binge Eating Disorder Clinical Trials by Type
Figure 12: Binge Eating Disorder Clinical Trials by Sponsor Type
Figure 13: Binge Eating Disorder Clinical Trials by Leading Sponsors
Figure 14: Binge Eating Disorder Average Enrollment by Phase
Figure 15: Binge Eating Disorder Average Enrollment by Trial Status
Figure 16: Binge Eating Disorder Average Enrollment by Type
Figure 17: Binge Eating Disorder- Average Enrolment by Type of Sponsors
Figure 18: Binge Eating Disorder- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Binge Eating Disorder Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Binge Eating Disorder Clinical Trials and Enrolment
Table 5: Europe - Country wise Binge Eating Disorder Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Binge Eating Disorder Clinical Trials and Enrolment
Table 7: North America - Country wise Binge Eating Disorder Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Binge Eating Disorder Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Binge Eating Disorder Average Enrollment by Phase
Table 15: Binge Eating Disorder Average Enrollment by Trial Status
Table 16: Binge Eating Disorder Average Enrollment by Type
Table 17: Binge Eating Disorder- Average Enrolment by Type of Sponsors
Table 18: Binge Eating Disorder- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Allergan Plc
  • Dr. Reddy's Laboratories Ltd
  • Jenson Pharmaceutical Services Ltd
  • Johnson & Johnson
  • Lotus Labs Pvt Ltd
  • Opiant Pharmaceuticals Inc
  • QPS Holdings LLC
  • Radiant Research Inc
  • Shire Plc
  • Sumitomo Dainippon Pharma Co Ltd
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4767298
Adroll
adroll